What Happens to Testosterone Levels With Age: The Clinical Context

The pattern of testosterone decline with age

Testosterone production peaks in the late teens and early twenties. The subsequent decline is gradual and continuous: approximately 1–2% per year after age 30 in most men, based on longitudinal cohort studies. This decline is driven by both declining testicular function (the testes produce less testosterone per unit of LH stimulation) and changes in the hypothalamic-pituitary regulation (the pituitary releases somewhat less LH over time).

The consequence at the population level: the average 60-year-old man has roughly 40% less total testosterone than the average 25-year-old. But this population-level average obscures wide individual variation. Some men maintain testosterone levels in the upper range of normal well into their 70s; others see clinically significant decline before age 45.

What drives the variation

The rate and extent of testosterone decline is not predetermined. Several modifiable factors substantially accelerate it:

Obesity and insulin resistance. Adipose tissue, particularly visceral fat, converts testosterone to oestrogen through aromatase activity. Insulin resistance directly suppresses LH release from the pituitary. A man who is significantly overweight and insulin-resistant may have testosterone levels decades "older" than his chronological age.

Metabolic disease. Type 2 diabetes, hypertension, and dyslipidaemia are each independently associated with lower testosterone in Indian men. The Yadav 2019 study found that Indian men with metabolic syndrome had substantially higher rates of testosterone deficiency than age-matched men without it.

Chronic illness. Any chronic inflammatory state — including untreated hypothyroidism, sleep apnoea, and chronic infection — suppresses testosterone through inflammatory cytokine effects on the HPG axis.

Sleep deprivation. Most testosterone production occurs during sleep, particularly during slow-wave sleep. Chronic sleep deprivation measurably reduces testosterone levels and is a reversible contributor.

Alcohol. Regular heavy alcohol use directly suppresses testicular testosterone production and is associated with lower testosterone levels independent of other factors.

Sedentary behaviour. Physical activity, particularly resistance training, acutely and sustainably raises testosterone levels. Prolonged sedentary behaviour is associated with lower testosterone.

The concept of "age-related" decline: what it does and doesn't mean

The classification of testosterone decline as "age-related" does not mean it is:

1. Inevitable. A man who maintains healthy body weight, metabolic health, physical activity, and sleep quality may see far less decline than population averages suggest. Modifiable factors drive a substantial proportion of the apparent age-related decline.

2. Untreatable. Where testosterone falls to clinically significant levels and produces symptoms — meeting the criteria for TDS — evaluation and management is appropriate regardless of age. Age is not a criterion for withholding management; clinical need is.

3. Uniform. The rate of decline is highly individual. A 55-year-old with optimal metabolic health may have testosterone equivalent to a 35-year-old. A 38-year-old with significant insulin resistance and obesity may have testosterone equivalent to a 60-year-old.

The clinical threshold question

There is no universally agreed lower threshold for total testosterone below which all men are symptomatic and above which all men are asymptomatic. Reference ranges vary between laboratories and between guidelines. The European Association of Urology uses 12 nmol/L (approximately 350 ng/dL) as the biochemical threshold for TDS; the American Urological Association uses 300 ng/dL; individual practice varies.

These thresholds are population-derived, not physiologically determined. A man whose total testosterone falls from 700 ng/dL to 350 ng/dL may experience significant symptoms at 350 ng/dL — which is "within normal limits" by many references. Another man may feel entirely well at 320 ng/dL. This is why the diagnosis of TDS requires both symptoms and biochemistry, and why the clinical picture — not the laboratory reference range alone — determines management.

What a comprehensive evaluation adds

The value of a complete hormonal and metabolic evaluation is that it distinguishes:

• Testosterone decline as the primary driver of symptoms
• Metabolic disease as the primary driver (with secondary testosterone suppression)
• Age-related decline within a range that does not warrant hormonal management
• Other conditions (hypothyroidism, depression, sleep apnoea, anaemia) mimicking testosterone deficiency

Each of these clinical pictures has a different appropriate response. The evaluation provides the specificity that the testosterone number alone cannot.